9 months ago
SRPT
AnalystsBiren AminBiren Amin's Stock Forecasts
AnalystsBiren Amin
Analyst Ranking
Bottom 3%
#4866 out of 4984 analysts
Average Return
-15.59%
Win Rate
39%22 out of 57
Risk vs Reward
Poor
Good
Biren Amin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Solid Biosciences IncSLDB | +117.69% | $2.77 | $6.03 | 2025-05-15 - 2025-08-18 | Strong Buy |
Neurocrine Biosciences IncNBIX | +92.27% | $61.94 | $119.09 | 2017-10-02 - 2018-10-03 | Strong Buy |
Zentalis Pharmaceuticals IncZNTL | +67.39% | $35.57 | $59.54 | 2020-04-27 - 2021-04-28 | Strong Buy |
Lenz Therapeutics IncLENZ | +66.82% | $23.24 | $38.77 | 2025-04-13 - 2025-08-18 | Strong Buy |
Bridgebio Pharma IncBBIO | +59.83% | $30.67 | $49.02 | 2024-09-03 - 2025-08-18 | Strong Buy |
Biren Amin Analyst Color
Get additional color on Biren Amin's coverage of popular stocks
Biren Amin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 11 | Hold | $15.00 | -28.54% | Maintains | 22 days ago |
Bridgebio Pharma IncBBIO | 3 | Strong Buy | $68.00 | +38.72% | Maintains | a month ago |
Aclaris Therapeutics IncACRS | 1 | Strong Buy | $6.00 | +224.32% | Assumes | a month ago |
Context Therapeutics IncCNTX | 1 | Strong Buy | $4.00 | +358.72% | Reiterates | 2 months ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $17.00 | +181.92% | Maintains | 3 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $7.00 | +542.20% | Maintains | 3 months ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $51.00 | +31.55% | Maintains | 4 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $38.00 | +116.03% | Initiates Coverage On | 5 months ago |
Elevation Oncology IncELEV | 2 | Hold | $0.70 | +91.78% | Downgrades | 5 months ago |
Monopar TherapeuticsMNPR | 1 | Strong Buy | $76.00 | +121.83% | Assumes | 5 months ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $12.00 | +318.12% | Initiates Coverage On | 6 months ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $71.00 | +68.69% | Maintains | 6 months ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $4.00 | -10.51% | Downgrades | 7 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Strong Buy | $35.00 | +278.38% | Initiates Coverage On | 9 months ago |
Immunome IncIMNM | 3 | Strong Buy | $21.00 | +104.88% | Maintains | 9 months ago |
Arcellx IncACLX | 2 | Strong Buy | $115.00 | +60.12% | Maintains | 9 months ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $32.00 | +17.00% | Maintains | 9 months ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $70.00 | N/A | Maintains | 2 years ago |
Quince Therapeutics IncQNCX | 2 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 5 years ago |
Urovant Sciences LtdUROV | 1 | Hold | $16.25 | N/A | Downgrades | 5 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Kala Bio IncKALA | 2 | Hold | $500.00 | N/A | Downgrades | 5 years ago |
Immatics NvIMTX | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 5 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Strong Buy | $54.00 | N/A | Initiates Coverage On | 5 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Calithera Biosciences IncCALA | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 5 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $492.00 | N/A | Upgrades | 5 years ago |
Synthorx IncTHOR | 1 | Hold | $68.00 | N/A | Downgrades | 6 years ago |
Ayala Pharmaceuticals IncADXS | 2 | Hold | $2,400.00 | N/A | Downgrades | 7 years ago |
Armo Biosciences IncARMO | 1 | Hold | $50.00 | N/A | Downgrades | 7 years ago |
Bluebird Bio IncBLUE | 4 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $101.00 | N/A | Initiates Coverage On | 8 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $69.00 | N/A | Maintains | 8 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $155.00 | N/A | Initiates Coverage On | 8 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Minerva Neurosciences IncNERV | 4 | Strong Buy | $136.00 | N/A | Initiates Coverage On | 8 years ago |
Obseva SaOBSVF | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.